Holen Sie sich die Stockscreener-App
22.06
1.34%
-0.30
Handel nachbörslich:
22.56
0.50
+2.27%
Schlusskurs vom Vortag:
$22.36
Offen:
$22.52
24-Stunden-Volumen:
1.80M
Relative Volume:
1.25
Marktkapitalisierung:
$2.83B
Einnahmen:
$2.89B
Nettoeinkommen (Verlust:
$-33.80M
KGV:
-81.70
EPS:
-0.27
Netto-Cashflow:
$204.10M
1W Leistung:
+1.01%
1M Leistung:
+14.30%
6M Leistung:
+8.40%
1J Leistung:
-21.72%
1-Tages-Spanne:
$21.97
$22.88
1-Wochen-Bereich:
$21.83
$22.88
52-Wochen-Spanne:
$18.87
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Vergleichen Sie SGRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
22.06 | 2.80B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
350.97 | 89.45B | 71.59B | 5.78B | 4.95B | 22.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.80 | 15.77B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
THC
Tenet Healthcare Corp
|
155.97 | 16.05B | 20.52B | 1.46B | 1.41B | 15.12 |
|
DVA
Davita Inc
|
146.05 | 10.62B | 12.82B | 936.34M | 1.47B | 10.74 |
|
EHC
Encompass Health Corp
|
108.39 | 10.81B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Is Surgery Partners Inc. a good long term investmentSuperior portfolio returns - Autocar Professional
Surgery Partners Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - jammulinksnews.com
What drives Surgery Partners Inc. stock priceExponentially increasing returns - jammulinksnews.com
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
What analysts say about Surgery Partners Inc. stockOutstanding stock performance - Autocar Professional
Long Term Trading Analysis for (SGRY) - news.stocktradersdaily.com
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Re - GuruFocus
Surgery Partners, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call Details - The Manila Times
Surgery Partners Sets Q2 Earnings Date: Key Financial Updates Coming August 5 - Stock Titan
Surgery Partners Stock Rises on Positive Analyst OutlookNews and Statistics - IndexBox
Why Surgery Partners (SGRY) Stock Is Trading Up Today - TradingView
Surgery Partners stock rises as CMS proposes favorable ASC rule changes - Investing.com Canada
Surgery Partners, Inc. (SGRY): A Bull Case Theory - Insider Monkey
1 Healthcare Stock to Keep an Eye On and 2 to Be Wary Of - Yahoo Finance
Surgery Partners stock rating reiterated by Cantor Fitzgerald at Overweight - Investing.com
(SGRY) Technical Data - news.stocktradersdaily.com
U.S. Ambulatory Surgery Center Market Growth in Future Scope - openPR.com
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Surgery Partners stock holds Buy rating at UBS on rejected Bain offer - Investing.com Canada
Surgery Partners stock hits 52-week low at 19.49 USD - Investing.com
Surgery Partners: The Plunge Doesn't Justify An Upgrade (NASDAQ:SGRY) - Seeking Alpha
Ascension Buying AmSurg in Response to Outpatient Trend - Healthcare Innovation
U.S. Ambulatory Surgery Center Market Generated - openPR.com
UBS reiterates buy rating on Surgery Partners stock amid takeover rejection - Investing.com
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures By Investing.com - Investing.com UK
Surgery Partners ends acquisition talks with Bain Capital By Investing.com - Investing.com India
Surgery Partners’ SWOT analysis: stock outlook amid pricing pressures - Investing.com
Surgery Partners rejects Bain Capital's takeover proposal - MSN
Surgery Partners Rejects $3.3B Bain Offer - USA Herald
Surgery Partners Ends Buyout Talks with Bain Capital, Shares Slide - GuruFocus
Surgery Partners Rejects $3.3B Bain Offer, Eyes Public Growth - Law360
Surgery Partners rejects Bain Capital's take-private offer - Reuters
Surgery Partners rejects Bain Capital's acquisition offer, opts to remain public - The Business Journals
RSI Alert: Surgery Partners (SGRY) Now Oversold - Nasdaq
Surgery Partners falls after it rejects Bain Capital's take-private offer - TradingView
Surgery Partners’ Stock Dips Amid Expert Analysis of Latest Financials - timothysykes.com
Surgery Partners Stock Slumps 13% After Company Rejects Bain Capital’s Take-Private Proposal By Stocktwits - Investing.com India
Bain Capital Private Equity, LP cancelled the acquisition of remaining 60.7% stake in Surgery Partners, Inc.. - MarketScreener
Surgery Partners rejects Bain Capital’s take-private offer - 1470 & 100.3 WMBD
Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent - Benzinga
Surgery Partners rejects Bain Capital's takeover proposal (SGRY) - Seeking Alpha
Surgery Partners stock falls after concluding discussions with Bain Capital - Investing.com
Surgery Partners ends acquisition talks with Bain Capital - Investing.com
Surgery Partners Decides to Remain Independent - TipRanks
Surgery Partners (SGRY) Confirms 2025 Financial Projections | SG - GuruFocus
Surgery Partners, Bain Capital conclude discussions - TipRanks
SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions - The Manila Times
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.27%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):